Clinical and Experimental Allergy - Prof Mo Shamji and Dr Boyle
A podcast by mshamji
6 Episodes
-
Oral Immunotherapy Should Play a Key Role in Preschool Food Allergy Management
Published: 4/14/2025 -
Diagnosis and Management of Lipid Transfer Protein Allergy—A BSACI Clinical Practice Statement
Published: 4/7/2025 -
Investigation of the Pathomechanism of Chronic Cough Using an In Vitro Approach
Published: 4/3/2025 -
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study
Published: 3/31/2025 -
NLRP1 Is a Prominent Inflammasome Sensor Found in Bronchial Epithelial Cells in Asthma and Can Be Activated by Rhinovirus A16
Published: 3/31/2025 -
Clinical and Experimental Allergy - Prof Shamji and Dr Boyle
Published: 12/21/2024
1 / 1
Summary This conversation highlights the significant contributions of the Clinical and Experimental Allergy (CEA) journal to the field of allergy research and clinical practice. The hosts and Editors-In-Chief discuss the journal’s achievements, including advancements in allergy diagnosis, innovative treatments, and a focus on patient-centric research. They also outline future directions for the journal, emphasising collaboration and accessibility in allergy research. Takeaways - CEA is a leading publication in allergy and immunology. - The journal publishes groundbreaking research on allergy mechanisms. - Innovative diagnostic methods are a focus of CEA’s contributions. - Promising new treatments, including biologics, are showcased. - Food allergy research informs better management practices. - Environmental factors influencing allergies are examined. - Patient-reported outcomes are prioritised in research. - The journal’s Impact Factor has reached a record high. - Future plans include enhancing author support and engagement. - Collaboration with patient organisations is a key focus for CEA.